Form 4: Bioxytran Director Alan Hoberman Reports Acquisition and Disposal of Common Stock
SEC Form 4
Director Alan Hoberman reports acquiring and disposing of Bioxytran, Inc. (BIXT) common stock on March 27, 2024.
Summary
- On March 27, 2024, Alan Hoberman, a director of Bioxytran, Inc. (BIXT), engaged in transactions involving the company's common stock.
- Hoberman acquired 266,955 shares of common stock at a price of $0.114 per share.
- Following the reported transactions, Hoberman directly owns 928,776 shares of Bioxytran common stock.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions by a company director, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, ensuring fair market practices.
Stakeholder Impact
- Shareholders are informed about the stock transactions of a company director, providing transparency into insider activity.
Key Dates
| Date | Description |
|---|---|
| 03/27/2024 | Date of stock acquisition and disposal transaction. |
Keywords
Bioxytran, BIXT, Alan Hoberman, Director, Form 4, Stock Transaction, Common Stock, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.